Related Experiment Video

Updated: Jul 19, 2026

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Hospital-acquired pneumonia: recent advances in diagnosis, microbiology and treatment

J D Bruchhaus1, R McEachern, G D Campbell

  • 1Division of Pulmonary and Critical Care Medicine, Louisiana State University Medical Center-Shreveport, Shreveport, LA 71130-3932, USA.

Current Opinion in Infectious Diseases
|October 13, 2006
PubMed

Insights

Hospital-acquired pneumonia remains common despite advances. This review covers recent literature on pneumonia causes, microbes, diagnosis, and antibiotic treatment effectiveness.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Critical Care Medicine

Background:

  • Nosocomial pneumonia is a frequent and severe hospital-acquired infection.
  • Despite preventative strategies, its incidence remains significant.
  • Advances in diagnostics and treatment have been made.

Purpose of the Study:

  • To review recent literature on hospital-acquired pneumonia.
  • To emphasize significant publications and advances.
  • To cover pathogenesis, microbiology, diagnosis, and antimicrobial therapy.

Main Methods:

  • Literature review of recent publications.
  • Emphasis on significant studies and advancements.
  • Focus on key areas: pathogenesis, microbiology, diagnosis, and treatment.

Main Results:

  • Recent literature highlights ongoing challenges in preventing hospital-acquired pneumonia.
  • Advances in understanding pneumonia pathogenesis and microbiology are noted.
  • New diagnostic approaches and antimicrobial treatment strategies are emerging.

Conclusions:

  • Hospital-acquired pneumonia continues to be a critical healthcare challenge.
  • Continued research into pathogenesis, microbiology, and diagnostics is essential.
  • Optimizing antimicrobial therapy remains a key focus for improving patient outcomes.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.